[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"general-population\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:general-population":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,42,62,86],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":24,"studyType":25,"phases":4,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100528902","capture-of-healthy-gut-bacteria-associated-to-high-fiber-diet-100528902",false,"NCT06166810","Capture of Healthy Gut Bacteria Associated to High Fiber Diet","In Silico and in Vitro Targeting of Healthy Gut Bacteria With Fiber Degrading Metabolic Potential","iTARGET","Inclusion Criteria:\n\n* Healthy adult subjects ;\n* Age between 20 and 50 (limits included) ;\n* BMI between 18.5 and 25 kg\u002Fm2 (excluding limits) ;\n* Consumption of more than 5 portions of fruit and vegetables a day;\n* Intake of at least 25g of dietary fibre per day;\n* A varied diet with little processed food.\n\nExclusion Criteria:\n\n* Antibiotics and\u002For transit modulators taken in the 3 months prior to sampling;\n* Known pathologies;\n* Current treatment;\n* History of digestive surgery having an impact on the microbiota, deemed incompatible with the study (bariatric surgery);\n* Consumption of food supplements based on protein preparations, probiotics or prebiotics;\n* Smoking (even occasionally);\n* Alcohol consumption \\> 2 glasses (i.e. 20 g) per day;\n* Intense sporting activity;\n* Pregnant or breast-feeding women;\n* Persons under legal protection (curatorship, guardianship, etc.);\n* Volunteers taking part in another intervention study;\n* Persons refusing to be registered on the French Ministry of Health's Fichier National des Volontaires Sains (National Register of Healthy Volunteers);\n* Subject not affiliated to the social security system;\n* Subject in a period of exclusion from a previous study or having received a total amount of compensation exceeding 6000 euros over the 12 consecutive months prior to the start of the trial (after verification in the Fichier des Volontaires pour la Recherche Biomédicale).",true,"ALL","20 Years","50 Years",{"count":22,"type":23},10,"ESTIMATED","24 Months","OBSERVATIONAL","The role of the intestinal microbiota on health is now well recognised, and diet is one of the factors influencing the maintenance of a healthy intestinal microbiota. More specifically, the consumption of fruit, vegetables and cereals is associated with good health and, in particular, with an increase in the relative abundance of bacterial groups described as beneficial. To date, a large number of bacterial species in the intestinal microbiota have yet to be isolated and cultivated, which limits the characterisation of their potential health benefits. In order to isolate and cultivate these intestinal bacteria, it is particularly relevant to recruit individuals with a high-fibre diet.",[28],"General Population","RECRUITING","2026-06-25",{"date":32,"type":33},"2026-06-29","ACTUAL",{"date":35,"type":33},"2023-10-24",{"date":37,"type":23},"2026-12-31",{"name":39,"class":40},"Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":17,"sex":18,"minAge":49,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":25,"phases":4,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":41},"100497570","le-french-gut-characterization-of-gut-microbiota-profiles-in-france-100497570","NCT05758961","Le French Gut: Characterization of Gut Microbiota Profiles in France","Le French Gut : the French Microbiota","Inclusion Criteria:\n\n* Persons over the age of 18 living in France.\n* Consent form signed electronically.\n\nNon inclusion Criteria:\n\n* Non-adult person (declarative);\n* Person not living in France (declarative);\n* Persons subject to a protective measure, in particular under guardianship or curatorship or unable to express their consent (declarative);\n* Person having had a colectomy (declarative);\n* Person with a digestive stoma (declarative);\n* Person who has not signed the consent;\n* Person who did not answer the entry questionnaire;\n* Person who has not sent a compliant stool sample;\n* Antibiotic intake in the 3 months before inclusion (declarative);\n* Performing a colonoscopy in the 3 months preceding inclusion (declarative).","18 Years",{"count":51,"type":23},100000,"\" The French Gut \" is a national contribution aiming to collect 100,000 faecal samples and associated nutritional and clinical data by 2027. Le French Gut is initiated by MetaGenoPolis-INRAE, supported by INRAE with Prof. R. Benamouzig, (AP-HP) as principal investigator of the project. The main goal of this national trial is a better understanding of the observed heterogeneity between gut microbiome of healthy subjects, its connections with the diet and lifestyle, but also changes in gut microbiota associated with diseases (diabetes, obesity, allergies, cancer, Parkinson, Alzheimer…).",[28],"2026-06-11",{"date":56,"type":33},"2026-06-15",{"date":58,"type":33},"2022-09-15",{"date":60,"type":23},"2042-09-15",{"name":39,"class":40},{"id":63,"slug":64,"hasResults":11,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":4,"eligibilityCriteria":68,"healthyVolunteers":17,"sex":18,"minAge":49,"maxAge":69,"enrollmentInfo":70,"targetDuration":4,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":41},"100464527","effects-of-vital-shower-on-quality-of-life-immune-function-cardiovascular-regulation-and-well-being-100464527","NCT05328856","Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being","An Randomised Controlled Trial on the Effects of Vital Shower (Hansgrohe) on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being","Inclusion Criteria:\n\n* Female and male patients between 18 and 70 years of age\n\nExclusion Criteria:\n\n* Bad general condition\n* Serious acute or chronic comorbidity\n* Pregnancy and breast feeding period\u002F in the next 6 months\n* Participation in a clinical trial within the last 3 months before enrollment\n* Simultaneous participation in another clinical trial\n* Raynaud's disease or cold agglutinin disease\n* Severe mental illness\n* Insufficiently treated dermatological diseases (e.g. neurodermatitis, psoriasis)\n* Non-compatible sanitary shower or bath devices","70 Years",{"count":71,"type":23},50,"INTERVENTIONAL",[74],"NA","The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.",[28],"2025-03-04",{"date":79,"type":33},"2025-03-06",{"date":81,"type":33},"2022-05-25",{"date":83,"type":23},"2025-12-31",{"name":85,"class":40},"Charite University, Berlin, Germany",{"id":87,"slug":88,"hasResults":11,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":4,"eligibilityCriteria":92,"healthyVolunteers":17,"sex":18,"minAge":49,"maxAge":4,"enrollmentInfo":93,"targetDuration":4,"studyType":72,"phases":95,"briefSummary":96,"conditions":97,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":102,"leadSponsor":104,"locationsCount":41},"100517449","data-collection-and-evaluation-of-optibp-under-investigational-use-100517449","NCT06017687","Data Collection and Evaluation of OptiBP Under Investigational Use","Data Collection and Evaluation of a Mobile, Machine-learning-based Solution for Blood Pressure Estimation - the OptiBP Study.","Inclusion Criteria:\n\n1. Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico);\n2. Live in the United States of America\n3. Have an Android smartphone\n4. Have access to an arm-worn blood pressure monitor (cuff)\n5. Have access to the Google Play store to download the OptiBP study app on their phone\n6. Be comfortable communicating in written and spoken English\n7. Be willing and able to provide informed consent to participate in the study\n\nExclusion Criteria:\n\n1. Known contact dermatitis to nickel\u002Fchromium\n2. Lesion or deficiency on hand, preventing placing a finger on the smartphone camera\n3. Known dysrhythmia like bigeminy, trigeminy, isolated VPB, atrial fibrillation",{"count":94,"type":23},500000,[74],"The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.",[28],"2023-09-28",{"date":100,"type":33},"2023-09-29",{"date":98,"type":33},{"date":103,"type":23},"2026-09",{"name":105,"class":106},"Biospectal","INDUSTRY"]